Cleared Traditional

K882347 - HARMAC EXTENSION INFUSION SET

K882347 is the FDA 510(k) clearance for HARMAC EXTENSION INFUSION SET by Harmac Medical Specialties, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K882347 · Harmac Medical Specialties, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
84d
Days
Class 2
Risk

K882347 is an FDA 510(k) clearance for the HARMAC EXTENSION INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Harmac Medical Specialties, Inc. (Buffalo, US). The FDA issued a Cleared decision on August 30, 1988 after a review of 84 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Harmac Medical Specialties, Inc. devices

Submission Details

510(k) Number K882347 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1988
Decision Date August 30, 1988
Days to Decision 84 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 129d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 449
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K882347.
VALLEYLAB I.V. ADMINISTRATION SETS
K883318 · Valleylab, Inc. · Oct 1988
LECTROSPIRAL
K883612 · Vygon Corp. · Sep 1988
SAFESITE INJECTION SITE AND BLUNT CANNULA
K883638 · Baxter Healthcare Corp · Sep 1988
IVAC(R) UNVENTED VOL. INFUSION SET MODEL 52080
K882302 · Y · Jul 1988
EXTENDED LIFE INJECTION SITE
K882007 · Baxter Healthcare Corp · Jun 1988
BLOOD/SOLUTION SET W/PRESSURE PUMP
K881321 · Baxter Healthcare Corp · Jun 1988